Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: idahoranch1 who wrote (7897)	10/19/2009 6:38:14 PM
From: kdd999	Read Replies (2) \| Respond to of 63329

Agree on the endpoints. That seemed ludicrous. I guess there is a LOT of dumb money on wall street. Last Friday on Fast Money the guy who plays options said that there was huge call buying on HGSI, and he even bought some calls. He glibly said they have a drug in Ph3 for lupus, and it's going to be a blockbuster. Not everybody is dumb. There's a fairly sizable short interest in that stock too (many more than in IMMU). HGSI will do a great job of marketing an ineffective drug. UCB will have an extra tough sale being a distant second onto the market. I do worry about that. Because of the nature of Lupus, a lot of people who take ineffective drugs won't figure it out for a long time.